Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Making Precision Medicine a Reality

Posted on April 24th, 2017 by in Chemistry

Precision medicine is no longer just a promising new development discussed only by medical professionals and industry insiders at conferences and in journals. In early 2015, former U.S. President Barack Obama announced the $215 million Precision Medicine Initiative Continue reading “Making Precision Medicine a Reality” »

Targeting Rare Diseases

Posted on March 20th, 2017 by in Pharma R&D

What is known as a “rare” disease might affect anywhere between a couple hundred to a couple hundred thousand people here in the U.S. And it’s estimated that as much as 10% of the nation’s population has one of the thousands of known rare diseases, most of which are genetic. Continue reading “Targeting Rare Diseases” »

Making Medicine More Precise

Posted on March 13th, 2017 by in Pharma R&D

Precision medicine, which takes the individual into account like never before, has been a thrilling development in the field of medicinal research. It is an area that has shown particular promise in the treatment of cancer, Continue reading “Making Medicine More Precise” »

Personalized vs. Precision Medicine

Posted on February 3rd, 2017 by in Pharma R&D

Last year was a year of impetus for precision medicine. Former President Obama’s budget for the 2016 fiscal year included $215 million for the National Institutes of Health (NIH), Continue reading “Personalized vs. Precision Medicine” »

  1. 1
  2. 2
  3. 3